159 related articles for article (PubMed ID: 20211687)
21. Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue.
Clyne CD; Kovacic A; Speed CJ; Zhou J; Pezzi V; Simpson ER
Mol Cell Endocrinol; 2004 Feb; 215(1-2):39-44. PubMed ID: 15026173
[TBL] [Abstract][Full Text] [Related]
22. Dietary flavones and flavonones display differential effects on aromatase (CYP19) transcription in the breast cancer cells MCF-7.
Li F; Ye L; Lin SM; Leung LK
Mol Cell Endocrinol; 2011 Sep; 344(1-2):51-8. PubMed ID: 21741436
[TBL] [Abstract][Full Text] [Related]
23. Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells.
Fleury L; Gerus M; Lavigne AC; Richard-Foy H; Bystricky K
Oncogene; 2008 Jul; 27(29):4075-85. PubMed ID: 18317449
[TBL] [Abstract][Full Text] [Related]
24. Regulation of aromatase expression in breast cancer tissue.
Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
[TBL] [Abstract][Full Text] [Related]
25. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women.
Agarwal VR; Ashanullah CI; Simpson ER; Bulun SE
J Clin Endocrinol Metab; 1997 Jan; 82(1):70-4. PubMed ID: 8989235
[TBL] [Abstract][Full Text] [Related]
26. Tissue-specific promoter methylation coincides with Cyp19 gene expression in buffalo (Bubalus bubalis) placenta of different stages of gestation.
Ghai S; Monga R; Mohanty TK; Chauhan MS; Singh D
Gen Comp Endocrinol; 2010 Nov; 169(2):182-9. PubMed ID: 20691690
[TBL] [Abstract][Full Text] [Related]
27. Aromatase activity induction in human adipose fibroblasts by retinoic acids via retinoic acid receptor α.
Wilde J; Erdmann M; Mertens M; Eiselt G; Schmidt M
J Mol Endocrinol; 2013 Oct; 51(2):247-60. PubMed ID: 24023268
[TBL] [Abstract][Full Text] [Related]
28. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression.
Wang Y; Man Gho W; Chan FL; Chen S; Leung LK
Br J Nutr; 2008 Feb; 99(2):303-10. PubMed ID: 17761019
[TBL] [Abstract][Full Text] [Related]
29. Interactions between prostaglandin E(2), liver receptor homologue-1, and aromatase in breast cancer.
Zhou J; Suzuki T; Kovacic A; Saito R; Miki Y; Ishida T; Moriya T; Simpson ER; Sasano H; Clyne CD
Cancer Res; 2005 Jan; 65(2):657-63. PubMed ID: 15695411
[TBL] [Abstract][Full Text] [Related]
30. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
31. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
32. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
[TBL] [Abstract][Full Text] [Related]
33. Paracrine-stimulated gene expression profile favors estradiol production in breast tumors.
Amin SA; Huang CC; Reierstad S; Lin Z; Arbieva Z; Wiley E; Saborian H; Haynes B; Cotterill H; Dowsett M; Bulun SE
Mol Cell Endocrinol; 2006 Jul; 253(1-2):44-55. PubMed ID: 16735089
[TBL] [Abstract][Full Text] [Related]
34. Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene.
Demura M; Martin RM; Shozu M; Sebastian S; Takayama K; Hsu WT; Schultz RA; Neely K; Bryant M; Mendonca BB; Hanaki K; Kanzaki S; Rhoads DB; Misra M; Bulun SE
Hum Mol Genet; 2007 Nov; 16(21):2529-41. PubMed ID: 17584767
[TBL] [Abstract][Full Text] [Related]
35. Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues.
Izawa M; Taniguchi F; Uegaki T; Takai E; Iwabe T; Terakawa N; Harada T
Fertil Steril; 2011 Jan; 95(1):33-9. PubMed ID: 20655525
[TBL] [Abstract][Full Text] [Related]
36. The promoter(s) of the aromatase gene in male testicular cells.
Carreau S; Bourguiba S; Lambard S; Silandre D; Delalande C
Reprod Biol; 2004 Mar; 4(1):23-34. PubMed ID: 15094793
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of a cAMP-responsive element in the region upstream from promoter 1.3 of the human aromatase gene.
Zhou D; Chen S
Arch Biochem Biophys; 1999 Nov; 371(2):179-90. PubMed ID: 10545204
[TBL] [Abstract][Full Text] [Related]
38. Androstenedione increases cytochrome P450 aromatase messenger ribonucleic acid transcripts in nonluteinizing bovine granulosa cells.
Hamel M; Vanselow J; Nicola ES; Price CA
Mol Reprod Dev; 2005 Feb; 70(2):175-83. PubMed ID: 15570613
[TBL] [Abstract][Full Text] [Related]
39. Methylseleninic acid is a novel suppressor of aromatase expression.
Gao R; Zhao L; Liu X; Rowan BG; Wabitsch M; Edwards DP; Nishi Y; Yanase T; Yu Q; Dong Y
J Endocrinol; 2012 Feb; 212(2):199-205. PubMed ID: 22128327
[TBL] [Abstract][Full Text] [Related]
40. An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells.
Izawa M; Harada T; Taniguchi F; Ohama Y; Takenaka Y; Terakawa N
Fertil Steril; 2008 May; 89(5 Suppl):1390-6. PubMed ID: 17662285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
